Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.24
-0.06 (-0.72%)
At close: Jan 8, 2026, 4:00 PM EST
8.24
0.00 (0.00%)
After-hours: Jan 8, 2026, 4:10 PM EST
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $143.99 million as of January 8, 2026. Its market cap has increased by 163.28% in one year.
Market Cap
143.99M
Enterprise Value
139.31M
1-Year Change
163.28%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $143.99M, a decrease of -53.88%. That is a compound annual growth rate of -25.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 145.04M | 4.27% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.17B |
| Johnson & Johnson | 495.70B |
| AbbVie | 391.97B |
| UnitedHealth Group | 317.05B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.37B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |